QUICKLINKS AND VIEW OPITONS
Less than 10% of people take Xenical or Meridia for a year; less than 2% take them for 2 years
Wednesday, October 03, 2007 5:27 am Email this article
Less than 10 percent of patients prescribed either Xenical (orlistat) or Meridia (sibutramine) are still taking them after one year, and less than 2 percent are still taking them after two years according to a study from the University of Alberta Hospital in Edmonton, Alberta, Canada. Subjects
Subjects: 17,000 users of Xenical, 3,500 users of Meridia
The study followed 17,000 users of Xenical (orlistat) and 3500 users of Meridia (sibutramine) who lived in British Columbia, Canada.
Conclusion: Most people does not use these drugs long-term
“This population-based, retrospective cohort analysis demonstrated very poor long-term persistence rates with orlistat and sibutramine and discontinuation rates that were much higher than those reported in clinical trials,” the researchers concluded.
Padwal R, Kezouh A, Levine M, Etminan M. Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes (Lond). 2007 Oct, 31(10):1567-70.
AUTHOR’S CONTACT INFORMATION
Dr. R. Padwal
Division of General Internal Medicine
2E3.22 Walter C. Mackenzie Health Sciences Center
University of Alberta Hospital
Edmonton, Alberta T6G 2B7
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.